Establishing a population-based register of monoclonal gammopathy of undetermined significance (MGUS) in Northern Ireland

Charlene M. McShane, Liam J. Murray, Anna T. Gavin, Eve Roman, Han-I Wang, Lesley A. Anderson

Research output: Contribution to conferenceUnpublished paperpeer-review

Abstract

Background:Monoclonal gammopathy of undetermined significance (MGUS), the most prevalent of the plasma cell dys-crasias precedes almost all cases of multiple myeloma (MM). Previous observational studies have reported an annual progression rate of 1% to MM and associated lymphoproliferative disorders and this risk has been reported to remain elevated beyond 25 years of observation. Recently, the term monoclnal gammopathy of renal significance (MGRS) was coined to reflect the association between kidney disease and monoclonal gammopathy. Associated with significant morbidity and mortality, MGRS has not yet been investigated at a population-based level. The aim of this project is to establish a population-based register of MGUS (and MGRS) within Northern Ireland (NI)
Original languageEnglish
DOIs
Publication statusPublished - 10 Jun 2015
EventNational Cancer Intelligence Network Cancer Outcomes Conference - Europa Hotel, Belfast, Belfast, United Kingdom
Duration: 8 Jun 201510 Jun 2015

Conference

ConferenceNational Cancer Intelligence Network Cancer Outcomes Conference
Country/TerritoryUnited Kingdom
CityBelfast
Period8/06/1510/06/15

Fingerprint

Dive into the research topics of 'Establishing a population-based register of monoclonal gammopathy of undetermined significance (MGUS) in Northern Ireland'. Together they form a unique fingerprint.

Cite this